Cosmax, Inc.

KSE 192820.KS

Cosmax, Inc. Revenue Per Share for the year ending December 31, 2023: USD 120.32

Cosmax, Inc. Revenue Per Share is USD 120.32 for the year ending December 31, 2023, a 7.99% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.
  • Cosmax, Inc. Revenue Per Share for the year ending December 31, 2022 was USD 111.42, a -10.35% change year over year.
  • Cosmax, Inc. Revenue Per Share for the year ending December 31, 2021 was USD 124.27, a 0.08% change year over year.
  • Cosmax, Inc. Revenue Per Share for the year ending December 31, 2020 was USD 124.17, a 10.68% change year over year.
  • Cosmax, Inc. Revenue Per Share for the year ending December 31, 2019 was USD 112.19, a 1.85% change year over year.
Key data
Date Revenue Per Share Dividend Per Share Free Cash Flow Per Share Return on Assets (ROA)
Market news
Loading...
KSE: 192820.KS

Cosmax, Inc.

CEO Mr. Jaecheon Kim
IPO Date April 7, 2014
Location South Korea
Headquarters #401 Pangyo inno valley E
Employees 1,390
Sector Consumer Discretionary
Industries
Description

Cosmax, Inc. researches, develops, produces, and sells cosmetic, health function food, and pharmaceutical products in Korea and internationally. The company offers skincare, color cosmetics, and hair care products, as well as mask sheets and eye patches. It also develops and manufactures medical supplies and devices; raw materials for cosmetic products; and functional containers and filling packaging products for cosmetics. The company was formerly known as Miroto Korea and changed its name to Cosmax, Inc. in 1994. Cosmax, Inc. was founded in 1992 and is headquartered in Hwaseong, South Korea.

Similar companies

161890.KS

Kolmar Korea Co., Ltd.

USD 38.94

0.04%

002790.KS

AMOREPACIFIC Group

USD 15.41

-0.14%

008770.KS

Hotel Shilla Co.,Ltd

USD 26.19

0.61%

051900.KS

LG H&H Co., Ltd.

USD 205.62

0.91%

090430.KS

Amorepacific Corporation

USD 78.63

-1.23%

StockViz Staff

January 15, 2025

Any question? Send us an email